Expert Speakers to Awe and Inspire
For this year’s Annual Meeting on Women’s Cancer, we’ve assembled a group of speakers from all aspects of healthcare to give you comprehensive education to broaden your perspective and enhance your practice.
Scott E. Page, PhD; Presidential Invited Guest Speaker
Martha “Meg” Gaines, JD, LLM; Presidential Invited Guest Speaker
Laurel W. Rice, MD; SGO Presidential Address
Jennifer Wargo, MD, MMSc; ABOG Lectureship
Robert E. Bristow, MD, MBA, FACS; Farr Nezhat Surgical Innovation Session
Saturday, March 24, 2018
2:00 p.m. – 2:45 p.m.
Leonid Hurwicz Collegiate Professor of Complex Systems Political Science, University of Michigan
Scott Page, PhD, is a professor and researcher at the University of Michigan who focuses on the myriad roles diversity plays in complex systems. His research delves into topics such as how diversity arises and whether diversity makes a system more productive, impacts robustness, and makes a system prone to large events.
Dr. Page has authored three books and published papers in a variety of disciplines including economics, political science, computer science, management, physics, public health, geography, urban planning, engineering, and history.
Saturday, March 24, 2018
2:45 p.m. – 3:15 p.m.
Director, Center for Patient Partnership
Distinguished Clinical Professor of Law, University of Wisconsin Law School
Martha “Meg” Gaines, JD, LLM, is a professor and patient advocate working to defend patient rights and teach healthcare professionals from all aspects of care how to do the same.
Gaines and several colleagues founded The Center for Patient Partnerships at the University of Wisconsin. The Center trains students from the schools of law, medicine, nursing, pharmacy, and social work to provide advocacy to cancer patients and conducts research about issues relevant to patient perspectives on patient care and healthcare delivery.
In collaboration with colleagues across departments, Gaines teaches a Patient Advocacy course in which students are put in interdisciplinary teams that help cancer patients understand their diagnoses and get the information necessary to make critical treatment decisions and support patient’s efforts to get the treatment they need.
Sunday, March 25, 2018
9:00 a.m. – 9:45 a.m.
SGO President 2017-2018
SGO President Laurel W. Rice, MD, is chair of the Department of Obstetrics and Gynecology and a professor in the Division of Gynecologic Oncology at the University of Wisconsin-Madison School of Medicine and Public Health. Nationally recognized as an expert in the care of women with gynecologic malignancies, Dr. Rice has published extensively in her field. Her research focuses on hormones and human malignancies, specifically endometrial carcinoma. She has lectured extensively throughout the United States. In addition to her leadership positions within the SGO, she is Past President of the Council of University Chairs of Obstetrics and Gynecology, President Elect of the American Gynecological & Obstetrical Society, and an active member of several other professional organizations. Since 2006, Dr. Rice has served on the American Board of Obstetrics and Gynecology and currently serves as a Representative on the Board of Directors. She is an examiner for candidates seeking board certification in both General Obstetrics and Gynecology, in addition to the subspecialty area of Gynecologic Oncology. She also serves as Associate Editor of Gynecologic Oncology, and as a reviewer for Obstetrics and Gynecology and the American Journal of Obstetrics and Gynecology.
Sunday, March 25, 2018
2:45 p.m. – 3:30 p.m.
Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center
Jennifer Wargo, MD, MMSc, is a surgeon and scientist dedicated to advancing the understanding and treatment of disease through science. Her fellowship training included two fellowships in surgical oncology with a particular focus on immunotherapy, and her subsequent research focuses especially on melanoma tumorigenesis and immunotherapy for cancer.
Her current research on resistance mechanisms and the effect of targeted therapy and immunotherapy on antitumor immunity continues to lead to a better understanding of responses to these therapies and the development of novel strategies to combat resistance.
Monday, March 26, 2018
11:15 a.m. – 12:30 p.m.
Robert E. Bristow, MD, MBA, FACS, is the Philip J. DiSaia Chair in the Gynecologic Oncology School of Medicine; Professor of Obstetrics and Gynecology and Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of California-Irvine. His research interests include health care outcomes and patterns of care for women with cancer of the ovary and endometrium.
Dr. Bristow has published extensively in the field of ovarian cancer research and is internationally regarded as a leading ovarian cancer surgeon. He was named one of America’s Top Doctors (Gynecologic Cancer, Ovarian Cancer), by Castle Connolly Medical Ltd., in 2012, and among the Best Doctors in America® (Obstetrics and Gynecology) five times in the last seven years.